These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 11922855

  • 1. Therapeutic potential of serotonin antagonists in depressive disorders.
    Wood MD, Thomas DR, Watson JM.
    Expert Opin Investig Drugs; 2002 Apr; 11(4):457-67. PubMed ID: 11922855
    [Abstract] [Full Text] [Related]

  • 2. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O, Wetzel H, Szegedi A.
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.
    Goodwin GM.
    J Clin Psychiatry; 1996 Sep; 57 Suppl 4():9-13. PubMed ID: 8636065
    [Abstract] [Full Text] [Related]

  • 5. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
    Blier P, de Montigny C.
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM.
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.
    Blier P, de Montigny C, Chaput Y.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():14-20; discussion 21. PubMed ID: 2157700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serotonin in panic disorder and social phobia.
    Sheehan DV, Raj BA, Trehan RR, Knapp EL.
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():63-77. PubMed ID: 7911142
    [Abstract] [Full Text] [Related]

  • 16. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
    den Boer JA, Westenberg HG, De Leeuw AS, van Vliet IM.
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic mechanisms and the new antidepressants.
    Stahl SM.
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.